Cytotoxic Agent

Doctoral researchers from 11 European institutions and four companies have formed a research network dedicated to developing molecules that stimulate the immune response to tumor cells.

Recent cytotoxic chemotherapy treatment did not appear associated with adverse COVID-19 outcomes for patients with cancer, according to results of a retrospective study published in Journal of Clinical Oncology.

Maintenance chemotherapy following initial treatment appeared to be more beneficial for patients with metastatic colorectal cancer than continuing a full induction regimen until disease progression, according to results of a meta-analysis of randomized clinical trials published in JAMA Oncology.